CYduct Diagnostics, Inc. carries a market capitalization of 6.50M, placing it among publicly traded companies globally.
| Market Cap | 6.50M |
| Enterprise Value | N/A |
CYduct Diagnostics, Inc.'s stock has gained approximately 391.86831% over the past 52 weeks. The 50-day moving average sits at 1.71, while the 200-day moving average is 0.93.
| Beta (5Y) | N/A |
| 52-Week Price Change | 391.86831% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 0.93 |
| Average Volume (20 Days) | N/A |
CYduct Diagnostics, Inc.'s most recent stock split took place on December 2, 2020 with a 250:1 split ratio.
| Last Split Date | 12/2/2020 |
| Split Ratio | 250:1 |